Chase Knickerbocker
Stock Analyst at Craig-Hallum
(2.71)
# 1,430
Out of 4,784 analysts
36
Total ratings
36.11%
Success rate
0.14%
Average return
Main Sectors:
Stocks Rated by Chase Knickerbocker
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ETON Eton Pharmaceuticals | Maintains: Buy | $23 → $26 | $13.02 | +99.69% | 5 | Mar 19, 2025 | |
| XERS Xeris Biopharma Holdings | Maintains: Buy | $5 → $6.5 | $5.58 | +16.49% | 1 | Mar 7, 2025 | |
| MDWD MediWound | Initiates: Buy | $39 | $15.95 | +144.51% | 1 | Feb 28, 2025 | |
| IRWD Ironwood Pharmaceuticals | Maintains: Buy | $10 → $8 | $1.41 | +467.38% | 4 | Jan 22, 2025 | |
| DCTH Delcath Systems | Maintains: Buy | $18 → $21 | $13.15 | +59.70% | 2 | Jan 17, 2025 | |
| KRMD KORU Medical Systems | Maintains: Buy | $5 → $6 | $2.59 | +131.66% | 2 | Jan 17, 2025 | |
| SCPH scPharmaceuticals | Maintains: Buy | $16 → $12 | $2.78 | +332.43% | 2 | Nov 14, 2024 | |
| PYPD PolyPid | Initiates: Buy | $10 | $2.74 | +264.96% | 1 | Nov 4, 2024 | |
| INDV Indivior | Maintains: Buy | $20 → $16 | $9.56 | +67.36% | 3 | Oct 11, 2024 | |
| HROW Harrow | Maintains: Buy | $45 → $65 | $26.21 | +148.00% | 3 | Oct 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $15 | $6.50 | +130.77% | 4 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $12 | $7.54 | +59.15% | 2 | Aug 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $7.34 | +36.24% | 1 | Jul 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $23 | $8.01 | +187.14% | 2 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $1 → $1.2 | $0.51 | +135.43% | 2 | Jul 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $21 | $6.60 | +218.18% | 1 | Mar 13, 2023 |
Eton Pharmaceuticals
Mar 19, 2025
Maintains: Buy
Price Target: $23 → $26
Current: $13.02
Upside: +99.69%
Xeris Biopharma Holdings
Mar 7, 2025
Maintains: Buy
Price Target: $5 → $6.5
Current: $5.58
Upside: +16.49%
MediWound
Feb 28, 2025
Initiates: Buy
Price Target: $39
Current: $15.95
Upside: +144.51%
Ironwood Pharmaceuticals
Jan 22, 2025
Maintains: Buy
Price Target: $10 → $8
Current: $1.41
Upside: +467.38%
Delcath Systems
Jan 17, 2025
Maintains: Buy
Price Target: $18 → $21
Current: $13.15
Upside: +59.70%
KORU Medical Systems
Jan 17, 2025
Maintains: Buy
Price Target: $5 → $6
Current: $2.59
Upside: +131.66%
scPharmaceuticals
Nov 14, 2024
Maintains: Buy
Price Target: $16 → $12
Current: $2.78
Upside: +332.43%
PolyPid
Nov 4, 2024
Initiates: Buy
Price Target: $10
Current: $2.74
Upside: +264.96%
Indivior
Oct 11, 2024
Maintains: Buy
Price Target: $20 → $16
Current: $9.56
Upside: +67.36%
Harrow
Oct 4, 2024
Maintains: Buy
Price Target: $45 → $65
Current: $26.21
Upside: +148.00%
Aug 14, 2024
Maintains: Buy
Price Target: $17 → $15
Current: $6.50
Upside: +130.77%
Aug 1, 2024
Maintains: Buy
Price Target: $14 → $12
Current: $7.54
Upside: +59.15%
Jul 11, 2024
Initiates: Buy
Price Target: $10
Current: $7.34
Upside: +36.24%
May 9, 2024
Maintains: Buy
Price Target: $22 → $23
Current: $8.01
Upside: +187.14%
Jul 11, 2023
Maintains: Buy
Price Target: $1 → $1.2
Current: $0.51
Upside: +135.43%
Mar 13, 2023
Initiates: Buy
Price Target: $21
Current: $6.60
Upside: +218.18%